Congress Asset Management Co. Buys 2,868 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Congress Asset Management Co. grew its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 0.9% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 307,266 shares of the medical equipment provider’s stock after buying an additional 2,868 shares during the period. Intuitive Surgical makes up approximately 1.0% of Congress Asset Management Co.’s holdings, making the stock its 21st biggest position. Congress Asset Management Co. owned about 0.09% of Intuitive Surgical worth $150,951,000 as of its most recent SEC filing.

Other hedge funds have also made changes to their positions in the company. Creekmur Asset Management LLC boosted its holdings in shares of Intuitive Surgical by 200.0% during the 1st quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider’s stock worth $25,000 after buying an additional 42 shares during the period. Ridgewood Investments LLC bought a new stake in shares of Intuitive Surgical in the second quarter valued at about $26,000. Delos Wealth Advisors LLC grew its position in Intuitive Surgical by 380.0% during the first quarter. Delos Wealth Advisors LLC now owns 72 shares of the medical equipment provider’s stock worth $29,000 after buying an additional 57 shares in the last quarter. Godsey & Gibb Inc. raised its holdings in Intuitive Surgical by 140.0% in the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock valued at $29,000 after acquiring an additional 35 shares in the last quarter. Finally, LRI Investments LLC bought a new stake in shares of Intuitive Surgical in the 1st quarter worth approximately $30,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insider Buying and Selling

In other news, EVP Robert Desantis sold 188 shares of Intuitive Surgical stock in a transaction that occurred on Tuesday, October 29th. The shares were sold at an average price of $506.52, for a total value of $95,225.76. Following the completion of the sale, the executive vice president now directly owns 5,506 shares in the company, valued at approximately $2,788,899.12. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. In other news, EVP Brian Edward Miller sold 2,553 shares of the business’s stock in a transaction on Tuesday, October 22nd. The stock was sold at an average price of $515.00, for a total transaction of $1,314,795.00. Following the completion of the transaction, the executive vice president now owns 7,066 shares of the company’s stock, valued at approximately $3,638,990. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Robert Desantis sold 188 shares of the business’s stock in a transaction that occurred on Tuesday, October 29th. The stock was sold at an average price of $506.52, for a total transaction of $95,225.76. Following the sale, the executive vice president now directly owns 5,506 shares in the company, valued at $2,788,899.12. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 50,095 shares of company stock valued at $24,552,712. 0.80% of the stock is owned by company insiders.

Intuitive Surgical Stock Performance

NASDAQ:ISRG traded down $4.19 during mid-day trading on Thursday, hitting $509.58. 99,775 shares of the stock were exchanged, compared to its average volume of 1,456,410. The stock has a market capitalization of $181.50 billion, a price-to-earnings ratio of 82.60, a price-to-earnings-growth ratio of 5.11 and a beta of 1.39. The firm’s 50-day simple moving average is $489.74 and its 200 day simple moving average is $445.30. Intuitive Surgical, Inc. has a fifty-two week low of $260.17 and a fifty-two week high of $523.34.

Analyst Ratings Changes

A number of equities analysts have recently commented on the stock. Truist Financial raised their price objective on shares of Intuitive Surgical from $520.00 to $570.00 and gave the stock a “buy” rating in a report on Monday, October 14th. Piper Sandler reissued an “overweight” rating and issued a $538.00 target price (up from $495.00) on shares of Intuitive Surgical in a report on Friday, October 18th. Royal Bank of Canada upped their price target on Intuitive Surgical from $525.00 to $555.00 and gave the company an “outperform” rating in a research report on Friday, October 18th. Raymond James boosted their target price on shares of Intuitive Surgical from $500.00 to $540.00 and gave the company an “outperform” rating in a research note on Monday, October 14th. Finally, Barclays boosted their price target on shares of Intuitive Surgical from $430.00 to $490.00 and gave the company an “overweight” rating in a research report on Thursday, July 18th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and fourteen have issued a buy rating to the stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $513.74.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.